# Solventum Corp: filings

SOLV · NYSE · CIK 1964738 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/solv.md) · [Financials](/companies/solv/financials.md) · [Filings](/companies/solv/filings.md) · [Insiders](/companies/solv/insiders.md)

## Reports and events: 44 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 122, 8-K 32, 3 26, UPLOAD 9, 10-Q 8, DRS/A 7, DRSLTR 6, CORRESP 5, IRANNOTICE 3, SCHEDULE 13G/A 3, 10-12B/A 2, 10-K 2, 424B7 2, DEF 14A 2, DEFA14A 2, EFFECT 2, SC 13G/A 2, SCHEDULE 13G 2, SD 2, SEC STAFF LETTER 2, 10-12B 1, 424B3 1, 4/A 1, ARS 1, CERT 1, DRS 1, FWP 1, POS AM 1, S-3ASR 1, S-4 1, S-8 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 17:27 ET | [10-Q](/filings/0001964738-26-000047.md) | Quarterly report, period 2026-06-30 | 0001964738-26-000047 |
| 2026-08-05 | 16:17 ET | [8-K](/filings/0001964738-26-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-26-000045 |
| 2026-08-05 | 16:11 ET | [8-K](/filings/0001964738-26-000043.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001964738-26-000043 |
| 2026-07-20 | 16:15 ET | [8-K](/filings/0001964738-26-000038.md) | 5.02 Departure or appointment of officers or directors | 0001964738-26-000038 |
| 2026-06-05 | 16:25 ET | [8-K](/filings/0001964738-26-000036.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001964738-26-000036 |
| 2026-05-27 | 16:23 ET | [8-K](/filings/0001964738-26-000031.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001964738-26-000031 |
| 2026-05-20 | 16:14 ET | [8-K](/filings/0001964738-26-000027.md) | 5.07 Shareholder vote results | 0001964738-26-000027 |
| 2026-05-05 | 17:29 ET | [10-Q](/filings/0001964738-26-000024.md) | Quarterly report, period 2026-03-31 | 0001964738-26-000024 |
| 2026-05-05 | 16:08 ET | [8-K](/filings/0001964738-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-26-000022 |
| 2026-03-27 | 16:15 ET | [DEF 14A](/filings/0001964738-26-000017.md) | Proxy statement, period 2025-12-31 | 0001964738-26-000017 |
| 2026-03-24 | 16:35 ET | [8-K](/filings/0001964738-26-000013.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001964738-26-000013 |
| 2026-02-27 | 13:40 ET | [10-K](/filings/0001964738-26-000007.md) | Annual report, period 2025-12-31 | 0001964738-26-000007 |
| 2026-02-26 | 16:08 ET | [8-K](/filings/0001964738-26-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-26-000005 |
| 2025-12-16 | 09:02 ET | [8-K](/filings/0001964738-25-000094.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001964738-25-000094 |
| 2025-11-06 | 17:14 ET | [10-Q](/filings/0001964738-25-000091.md) | Quarterly report, period 2025-09-30 | 0001964738-25-000091 |
| 2025-11-06 | 16:11 ET | [8-K](/filings/0001964738-25-000089.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-25-000089 |
| 2025-10-21 | 17:00 ET | [8-K](/filings/0001628280-25-045731.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-045731 |
| 2025-09-08 | 16:35 ET | [8-K](/filings/0001964738-25-000084.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001964738-25-000084 |
| 2025-09-02 | 08:01 ET | [8-K](/filings/0001964738-25-000078.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001964738-25-000078 |
| 2025-08-22 | 08:25 ET | [8-K](/filings/0001964738-25-000073.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001964738-25-000073 |
| 2025-08-15 | 16:13 ET | [8-K](/filings/0001140361-25-031512.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-031512 |
| 2025-08-13 | 16:12 ET | [8-K](/filings/0001140361-25-030803.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-030803 |
| 2025-08-08 | 18:13 ET | [10-Q](/filings/0001964738-25-000064.md) | Quarterly report, period 2025-06-30 | 0001964738-25-000064 |
| 2025-08-07 | 16:12 ET | [8-K](/filings/0001964738-25-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-25-000062 |
| 2025-06-25 | 16:34 ET | [8-K](/filings/0001964738-25-000056.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001964738-25-000056 |
| 2025-05-09 | 12:24 ET | [10-Q](/filings/0001964738-25-000051.md) | Quarterly report, period 2025-03-31 | 0001964738-25-000051 |
| 2025-05-08 | 16:13 ET | [8-K](/filings/0001964738-25-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-25-000049 |
| 2025-05-02 | 16:12 ET | [8-K](/filings/0001964738-25-000043.md) | 5.07 Shareholder vote results | 0001964738-25-000043 |
| 2025-03-21 | 16:12 ET | [DEF 14A](/filings/0001964738-25-000038.md) | Proxy statement, period 2024-12-31 | 0001964738-25-000038 |
| 2025-02-28 | 16:56 ET | [10-K](/filings/0001964738-25-000019.md) | Annual report, period 2024-12-31 | 0001964738-25-000019 |
| 2025-02-27 | 16:17 ET | [8-K](/filings/0001964738-25-000015.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001964738-25-000015 |
| 2025-02-27 | 16:12 ET | [8-K](/filings/0001964738-25-000013.md) | 2.02 Results of operations | 0001964738-25-000013 |
| 2024-11-08 | 15:57 ET | [10-Q](/filings/0001964738-24-000044.md) | Quarterly report, period 2024-09-30 | 0001964738-24-000044 |
| 2024-11-07 | 16:14 ET | [8-K](/filings/0001964738-24-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-24-000040 |
| 2024-11-05 | 16:11 ET | [8-K](/filings/0001964738-24-000036.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001964738-24-000036 |
| 2024-09-26 | 17:27 ET | [8-K](/filings/0001964738-24-000027.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001964738-24-000027 |
| 2024-08-09 | 13:54 ET | [10-Q](/filings/0001964738-24-000020.md) | Quarterly report, period 2024-06-30 | 0001964738-24-000020 |
| 2024-08-08 | 16:13 ET | [8-K](/filings/0001964738-24-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-24-000017 |
| 2024-05-17 | 17:07 ET | [8-K](/filings/0001964738-24-000014.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001964738-24-000014 |
| 2024-05-10 | 09:13 ET | [10-Q](/filings/0001964738-24-000013.md) | Quarterly report, period 2024-03-31 | 0001964738-24-000013 |
| 2024-05-09 | 06:50 ET | [8-K](/filings/0001964738-24-000012.md) | 2.02 Results of operations | 0001964738-24-000012 |
| 2024-04-16 | 16:35 ET | [8-K](/filings/0001964738-24-000010.md) | 5.02 Departure or appointment of officers or directors | 0001964738-24-000010 |
| 2024-04-04 | 16:41 ET | [8-K](/filings/0001628280-24-014887.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-014887 |
| 2024-03-13 | 17:12 ET | [8-K](/filings/0001628280-24-010988.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-010988 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.